Jenny R. Robertson, J.D.

Jenny R. Robertson, J.D.

Former Chief Legal OfficeratLexeo Therapeutics· In proxies 2022–2025

Pay in FY2025-14% from the year before · Lexeo Therapeutics stock +50.9% the same year

Jenny R. Robertson, J.D. was paid $2.1M in FY2025 (Dec), down 14%. Lexeo Therapeutics stock rose 50.9% that year.

Pay$100 in the stock at the end of FY23 → $74
Pay is from the Summary Compensation Table of each Lexeo Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lexeo TherapeuticsPublic company · 4 yr
    • Former Chief Legal Officer2022 – Present · 4 yrStock in role -69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?